TY - JOUR
T1 - A cross-sectional observation of effect of exposure to N-Methyl-2- Pyrrolidone (NMP) on workers' health
AU - Nishimura, Shigeru
AU - Yasui, Hirohiko
AU - Miyauchi, Hiroyuki
AU - Kikuchi, Yuriko
AU - Kondo, Nami
AU - Takebayashi, Toru
AU - Tanaka, Shigeru
AU - Mikoshiba, Yuko
AU - Omae, Kazuyuki
AU - Nomiyama, Tetsuo
PY - 2009/7
Y1 - 2009/7
N2 - This study was aimed at clarifying the effect of exposure to N-methyl-2-pyrrolidone (NMP) on workers' health. Fifteen male NMP-exposed workers and 15 referent male workers were recruited for this study. Exposure concentrations were assessed by determining NMP in the breathing zones and urinary NMP. Clinical examinations, motor and sensory nerve conduction velocities in the dominant arm, and neurobehavioral tests were carried out. The subjects were asked to complete self-administered questionnaires for subjective symptoms and psychological assessment. The mean NMP exposure concentrations ranged from 0.14 to 0.26 ppm, and urinary NMP levels at the end of each workday ranged from 0.17 to 0.22 mg/l, throughout the work week. In terms of clinical data, motor and sensory nerve conduction velocities, neurobehavioral tests, and subjective symptom assessments, there were no differences and no dose-dependent changes in either the means or the prevalence of abnormal findings between NMP-exposed and referent workers.
AB - This study was aimed at clarifying the effect of exposure to N-methyl-2-pyrrolidone (NMP) on workers' health. Fifteen male NMP-exposed workers and 15 referent male workers were recruited for this study. Exposure concentrations were assessed by determining NMP in the breathing zones and urinary NMP. Clinical examinations, motor and sensory nerve conduction velocities in the dominant arm, and neurobehavioral tests were carried out. The subjects were asked to complete self-administered questionnaires for subjective symptoms and psychological assessment. The mean NMP exposure concentrations ranged from 0.14 to 0.26 ppm, and urinary NMP levels at the end of each workday ranged from 0.17 to 0.22 mg/l, throughout the work week. In terms of clinical data, motor and sensory nerve conduction velocities, neurobehavioral tests, and subjective symptom assessments, there were no differences and no dose-dependent changes in either the means or the prevalence of abnormal findings between NMP-exposed and referent workers.
KW - Cross-sectional study
KW - Health effect
KW - N-methyl-2-pyrrolidone
KW - NMP
UR - http://www.scopus.com/inward/record.url?scp=69749103599&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=69749103599&partnerID=8YFLogxK
U2 - 10.2486/indhealth.47.355
DO - 10.2486/indhealth.47.355
M3 - Article
C2 - 19672008
AN - SCOPUS:69749103599
SN - 0019-8366
VL - 47
SP - 355
EP - 362
JO - Industrial Health
JF - Industrial Health
IS - 4
ER -